![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 3, 1647-1655, January 17, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
, and
From the Divisions of Burkholderia cepacia is a bacterium
with increasing importance as a pathogen in patients with cystic
fibrosis. The deep-rough mutant Ko2b was generated from B. cepacia type strain ATCC 25416 by insertion of a kanamycin
resistance cassette into the gene waaC encoding
heptosyltransferase I. Mass spectrometric analysis of the
de-O-acylated lipopolysaccharide (LPS) of the mutant showed that it consisted of a bisphosphorylated glucosamine backbone with two
3-hydroxyhexadecanoic acids in amide-linkage, 4-amino-4-deoxyarabinose (Ara4N) residues on both phosphates, and a core oligosaccharide of the
sequence Ara4N-(1
Medical and Biochemical
Microbiology, ¶ Molecular Infection Biology, and
Biophysics, Research Center Borstel, Center for Medicine and
Biosciences, Parkallee 22, D-23845 Borstel, Germany
8)
D-glycero-D-talo-oct-2-ulosonic acid
(Ko)-(2
4)3-deoxy-D-manno-oct-2-ulosonic
acid (Kdo). The mutant allowed investigations on the biosynthesis of
the LPS as well as on its role in human infection. Mutant Ko2b showed
no difference in its ability to invade human macrophages as compared with the wild type. Furthermore, isolated LPS of both strains induced the production of tumor necrosis factor
from macrophages to
the same extent. Thus, the truncation of the LPS did not decrease the
biological activity of the mutant or its LPS in these aspects.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AJ302064 and AJ420777.
§ To whom correspondence should be addressed: Division of Medical and Biochemical Microbiology Research Center Borstel, Center for Medicine and Biosciences, Parkallee 22, D-23845 Borstel, Germany. Tel.: 49-4537-188469; Fax: 49-4537-188419; E-mail: sgronow@fz-borstel.de.This article has been cited by other articles:
![]() |
A. De Soyza, A. Silipo, R. Lanzetta, J. R. Govan, and A. Molinaro Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides Innate Immunity, June 1, 2008; 14(3): 127 - 144. [Abstract] [PDF] |
||||
![]() |
X. P. Ortega, S. T. Cardona, A. R. Brown, S. A. Loutet, R. S. Flannagan, D. J. Campopiano, J. R. W. Govan, and M. A. Valvano A Putative Gene Cluster for Aminoarabinose Biosynthesis Is Essential for Burkholderia cenocepacia Viability J. Bacteriol., May 1, 2007; 189(9): 3639 - 3644. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Loutet, R. S. Flannagan, C. Kooi, P. A. Sokol, and M. A. Valvano A Complete Lipopolysaccharide Inner Core Oligosaccharide Is Required for Resistance of Burkholderia cenocepacia to Antimicrobial Peptides and Bacterial Survival In Vivo J. Bacteriol., March 15, 2006; 188(6): 2073 - 2080. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gronow, W. Brabetz, B. Lindner, and H. Brade OpsX from Haemophilus influenzae Represents a Novel Type of Heptosyltransferase I in Lipopolysaccharide Biosynthesis J. Bacteriol., September 1, 2005; 187(17): 6242 - 6247. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Silipo, A. Molinaro, P. Cescutti, E. Bedini, R. Rizzo, M. Parrilli, and R. Lanzetta Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide Glycobiology, May 1, 2005; 15(5): 561 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimomura, M. Matsuura, S. Saito, Y. Hirai, Y. Isshiki, and K. Kawahara Unusual Interaction of a Lipopolysaccharide Isolated from Burkholderia cepacia with Polymyxin B Infect. Immun., September 1, 2003; 71(9): 5225 - 5230. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |